Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25 EBIT

Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25 (FCRX) currently reports a EBIT of $63M as of March 2025. That compares with $270M in the prior-year period — down 76.7% year over year. That is below the Finance sector average of $24T. Use the charts on this page to explore Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's EBIT history and peer comparisons.

Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's EBIT decreased from $270M to $63M — a 76.7% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's EBIT of $63M is lower than the Finance sector average of $24T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25 reported $63M in EBIT as of March 2025. That compares with $270M in the prior-year period — down 76.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is $24T. From there, open related valuation or income-statement pages for Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25, and consider following FCRX for alerts when major investors trade the stock.